These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 21670184

  • 1. Efficacy of human simulated exposures of ceftaroline administered at 600 milligrams every 12 hours against phenotypically diverse Staphylococcus aureus isolates.
    Keel RA, Crandon JL, Nicolau DP.
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4028-32. PubMed ID: 21670184
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of human simulated exposures of ceftaroline against phenotypically diverse Enterobacteriaceae isolates.
    Housman ST, Keel RA, Crandon JL, Williams G, Nicolau DP.
    Antimicrob Agents Chemother; 2012 May; 56(5):2576-80. PubMed ID: 22330908
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamics of ceftaroline against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infection.
    MacGowan AP, Noel AR, Tomaselli S, Bowker KE.
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2451-6. PubMed ID: 23459495
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of ceftaroline fosamil in a staphylococcal murine pneumonia model.
    Bhalodi AA, Crandon JL, Biek D, Nicolau DP.
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6160-5. PubMed ID: 22985880
    [Abstract] [Full Text] [Related]

  • 5. Pharmacodynamics of tigecycline against phenotypically diverse Staphylococcus aureus isolates in a murine thigh model.
    Crandon JL, Banevicius MA, Nicolau DP.
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1165-9. PubMed ID: 19114676
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model.
    Singh R, Almutairi M, Alm RA, Lahiri SD, San Martin M, Chen A, Ambler JE.
    J Antimicrob Chemother; 2017 Oct 01; 72(10):2796-2803. PubMed ID: 29091195
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro activity of human-simulated epithelial lining fluid exposures of ceftaroline, ceftriaxone, and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus.
    MacVane SH, So W, Nicolau DP, Kuti JL.
    Antimicrob Agents Chemother; 2014 Dec 01; 58(12):7520-6. PubMed ID: 25288076
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the in vivo efficacy of ceftaroline fosamil, vancomycin and daptomycin in a murine model of methicillin-resistant Staphylococcus aureus bacteraemia.
    García P, Moscoso M, Fernández MC, Fuentes-Valverde V, Pérez A, Bou G.
    Int J Antimicrob Agents; 2023 Jul 01; 62(1):106836. PubMed ID: 37150362
    [Abstract] [Full Text] [Related]

  • 13. Evaluating the antibacterial activity of ceftaroline against clinical isolates of methicillin-susceptible and- resistant Staphylococcus aureus in Kuwait hospitals.
    Alfouzan W, Boswihi SS, Dhar R, Udo E.
    J Infect Public Health; 2020 Oct 01; 13(10):1589-1591. PubMed ID: 32859552
    [Abstract] [Full Text] [Related]

  • 14. Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program.
    Sader HS, Flamm RK, Farrell DJ, Jones RN.
    Clin Infect Dis; 2012 Sep 01; 55 Suppl 3():S181-6. PubMed ID: 22903950
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Supporting the ceftaroline fosamil/avibactam Enterobacteriaceae breakpoint determination using humanised in vivo exposures in a thigh model.
    Bhalodi AA, Crandon JL, Williams G, Nicolau DP.
    Int J Antimicrob Agents; 2014 Dec 01; 44(6):508-13. PubMed ID: 25278330
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.